ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01937468
Recruitment Status : Active, not recruiting
First Posted : September 9, 2013
Last Update Posted : January 26, 2018
Sponsor:
Collaborators:
Miltenyi Biotec GmbH
Prometheus Laboratories
National Cancer Institute (NCI)
Information provided by (Responsible Party):
John Koreth, MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : August 2017
  Estimated Study Completion Date : November 2020